Introduction: Hypothalamic gliosis is linked to obesity and is known to be induced by dietary factors in rodent models including high-fat, fructose-rich, and sucrose-enriched diet. This longitudinal analysis evaluated whether dietary exposures are associated with the degree of hypothalamic gliosis as assessed at MRI examinations obtained 5-8 years later.

Methods: Dietary exposures and brain MRI images were collected from 867 adults. Self-reported food frequency questionnaires were obtained and daily consumption of % total fat, % total carbohydrates, % total protein, % saturated fat, % fructose, and % sucrose of total energy intake were calculated and used as dietary exposures. To calculate the primary outcome, MRI T2 signal intensities were extracted to calculate a ratio of mediobasal hypothalamus (MBH)/amygdala (AMY), a greater ratio suggesting evidence of gliosis; a positive control ratio of MBH/putamen (PUT); and a negative control ratio of PUT/AMY. Linear regression evaluated the association between each dietary exposure and the outcomes of T2 signal ratios adjusting for age, sex, and BMI.

Results: The average age was 54.9±8.8 y (54.9% female). There were no statistically significant associations between % total fat, % saturated fat, % fructose, % sucrose, % total carbohydrates, and % total protein with the degree of MBH gliosis (MBH/AMY) as assessed at MRI examinations obtained 5-8y later (P = 0.89, 0.79, 0.42, 0.90, 0.71, 0.63, respectively). No associations were found between the dietary exposures and the positive or negative control ratio.

Conclusion: We did not find evidence of prospective associations between self-reported diet and MRI evidence of MBH gliosis. However, further research is warranted given the limitations of self-reported diet data and the extended time interval between the dietary exposure and MRI measurements.

Disclosure

D. Yeum: None. J. Lo: None. S.J. Melhorn: None. K. Olerich: None. A. Huang: None. S. Kee: None. C. DeCarli: None. A. Beiser: None. S. Seshadri: None. E.A. Schur: Consultant; Amgen Inc.

Funding

National Institute of Health (5K24HL144917)

Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at http://www.diabetesjournals.org/content/license.